Veru Inc. (VERU)

Longboard Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	19.62	24.92	9.63	80.19	122.36	13.59
Cash & Short-Term Investments	19.62	24.92	9.63	80.19	122.36	13.59
Cash Growth	-43.53%	158.86%	-88.00%	-34.46%	800.45%	115.86%
Accounts Receivable	-	3.96	4.51	3.55	8.79	5.23
Receivables	-	3.96	4.51	3.55	13.79	5.23
Inventory	-	4.14	6.7	8.62	5.57	6.7
Prepaid Expenses	1.36	1.78	1.1	1.96	0.85	0.88
Other Current Assets	-	0.42	1.01	9.68	9.17	0.61
Total Current Assets	21.38	35.22	22.93	104	151.75	27.01
Property, Plant & Equipment	3.43	4.85	5.99	5.97	1.56	1.67
Goodwill	6.88	6.88	6.88	6.88	6.88	6.88
Other Intangible Assets	-	-	0.01	3.98	4.05	5.75
Long-Term Accounts Receivable	-	-	-	0.71	-	-
Long-Term Deferred Tax Assets	-	12.34	12.71	12.97	13.02	9.47
Long-Term Deferred Charges	0.87	0.9	1.2	0.58	0.58	0.58
Other Long-Term Assets	0.12	0.23	0.31	0.27	0.3	0.19
Total Assets	32.67	60.42	50.02	135.36	178.15	51.54
Accounts Payable	2.21	3.04	12.93	22	3.41	2.81
Accrued Expenses	2.67	6.34	2.78	14.24	8.49	4.36
Short-Term Debt	-	-	0.1	-	-	-
Current Portion of Long-Term Debt	-	1.03	0.86	1.17	3.24	6.94
Current Portion of Leases	0.75	1.07	1.04	0.96	0.5	0.61
Current Unearned Revenue	-	0.4	0.1	0.34	0.13	0.01
Total Current Liabilities	5.62	11.87	17.81	38.71	15.77	14.73
Long-Term Debt	-	8.85	8.87	9.66	9.4	5.62
Long-Term Leases	2.64	2.92	3.63	4.09	0.61	1
Long-Term Deferred Tax Liabilities	-	-	-	0.08	0.06	0.07
Other Long-Term Liabilities	3.36	4.46	0.03	0.02	0.01	0.01
Total Liabilities	11.62	28.1	30.34	52.56	25.85	21.43
Common Stock	1.49	1.49	0.94	0.83	0.82	0.72
Additional Paid-In Capital	338.78	333.79	283.89	253.97	241.66	126.97
Retained Earnings	-311.42	-294.57	-256.77	-163.62	-81.8	-89.19
Treasury Stock	-7.81	-7.81	-7.81	-7.81	-7.81	-7.81
Comprehensive Income & Other	-	-0.58	-0.58	-0.58	-0.58	-0.58
Shareholders' Equity	21.05	32.32	19.68	82.8	152.29	30.11
Total Liabilities & Equity	32.67	60.42	50.02	135.36	178.15	51.54
Total Debt	3.39	13.86	14.51	15.88	13.74	14.17
Net Cash (Debt)	16.23	11.05	-4.88	64.31	108.62	-0.58
Net Cash Growth	-21.62%	-	-	-40.79%	-	-
Net Cash Per Share	0.11	0.08	-0.06	0.80	1.30	-0.01
Filing Date Shares Outstanding	146.58	146.38	93.67	80.62	80.03	70.08
Total Common Shares Outstanding	146.58	146.38	91.78	80.51	79.97	69.86
Working Capital	15.76	23.36	5.12	65.29	135.99	12.29
Book Value Per Share	0.14	0.22	0.21	1.03	1.90	0.43
Tangible Book Value	14.17	25.44	12.79	71.94	141.37	17.48
Tangible Book Value Per Share	0.10	0.17	0.14	0.89	1.77	0.25
Machinery	0.77	4.34	4.48	4.34	3.87	3.56
Leasehold Improvements	0.2	0.96	0.96	0.48	0.3	0.3

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q